6533b856fe1ef96bd12b2fb8
RESEARCH PRODUCT
Additional file 6: Figure S4. of Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial
Christopher PapandreouMònica BullòFrancisco TinahonesMiguel Martínez-gonzálezDolores CorellaGeorgios FragkiadakisJosé López-mirandaRamon EstruchMontserrat FitóJordi Salas-salvadósubject
description
Principal component analysis (PCA) to discriminate between the baseline and final states in group 3 (suspected NAFLD reversion cases). Model diagnostics (A = 6, R2X = 0.628, Q2X = 0.235) (DOCX 42 kb)
year | journal | country | edition | language |
---|---|---|---|---|
2017-01-01 |